---
title: "OrbiMed Advisors acquires 1.940.000 Braveheart Bio common shares worth $ 34,92 juta"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295583346.md"
description: "OrbiMed Advisors increased its indirect ownership in Braveheart Bio to 11,901,826 common shares. This position includes 9,132,420 shares converted from Series A Preferred Stock and 1,940,000 newly purchased shares at $18 per share."
datetime: "2026-08-11T21:28:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295583346.md)
  - [en](https://longbridge.com/en/news/295583346.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295583346.md)
generator: "portal-rs"
---

# OrbiMed Advisors acquires 1.940.000 Braveheart Bio common shares worth $ 34,92 juta

-   Braveheart Bio melaporkan OrbiMed Advisors meningkatkan kepemilikan tidak langsung menjadi 11.901.826 saham biasa. \* Posisi itu mencakup 9.132.420 saham biasa dari konversi Series A Preferred Stock. \* OrbiMed juga membeli 1.940.000 saham biasa pada harga USD 18 per saham. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Braveheart Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000782), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BRVE.US](https://longbridge.com/en/quote/BRVE.US.md)

## Related News & Research

- [AH Bio Fund IV Discloses Investment at Braveheart Bio with 11.4% Stake](https://longbridge.com/en/news/295977626.md)
- [Braveheart Bio director Vineeta Agarwala files initial beneficial ownership statement](https://longbridge.com/en/news/295976985.md)
- [Exmar announces availability of 2026 half-year results release](https://longbridge.com/en/news/296992548.md)
- [Maia Bio director Ramiro Guerrero acquires 1,794 common shares worth $2,386.02](https://longbridge.com/en/news/297040658.md)
- [Eiffage announces availability of H1 2026 results report](https://longbridge.com/en/news/297066901.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**